Canakinumab Study in Individuals With Newly Diagnosed Type 1 Diabetes

Clinical trial NCT00947427 · COMPLETED

Trial details

NCT number: NCT00947427
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 1 Diabetes Preservation of Insulin Secretion Newly Diagnosed Type 1 Diabetes Canakinumab in Type 1 Diabetes

Start date: 2010-10-01
Primary completion: 2013-04-01
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.